We performed the immunophenotyping of 101 patients with B-cell non-Hodgkin'
s lymphoma (B-NHL) using two-colour flow cytometry (FCM) and found that lym
phoma cells coexpressed at least one kind of T-cell-associated antigen (T-A
g: CD2, CD5, CD7) in 25 patients (24.8%). Among these three T-Ags, CD5 was
the most frequently expressed, in 21 patients (20.8%), followed by CD7, exp
ressed in five patients (50%), and CD2, which was expressed in two patients
(2.0%). Two kinds of T-Ag were simultaneusly expressed in three patients (
CD2/CD5, CD2/ CD7, and CD5/CD7, each expressed in one patient). Concerning
the expression pattern of T-Ag, there were no significant differences betwe
en lymph nodes and extranodal organs in the three patients with T-Ag-positi
ve B-NHL (T-Ag(+) B-NHL) who were analysed, When comparing the clinical fea
tures between T-Ag(+) B-NHL and T-Ag-negative B-NHL (T-Ag(-) B-NHL), extran
odal involvement and higher International Prognostic Index (H and H.I.) wer
e significantly frequent in the former subgroup (P = 0.0119 and P = 0.0302
respectively).